Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat

Cancer Letters

Volumn 213, Issue 1, 2004, Pages 21-29

  Fujita, Ken Ichi ^a   Matsuda, Eiji ^a   Sekine, Kazunori ^a   Iigo, Masaaki ^a   Tsuda, Hiroyuki ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Apoptosis; Bid; Chemoprevention; Colon carcinogenesis; Fas; Lactoferrin

Indexed keywords

AZOXYMETHANE; FAS LIGAND; LACTOFERRIN; PROTEIN BCL 2; PROTEIN BID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; AZOXYMETHANE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; COLONIC NEOPLASMS; CYCLIN D1; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; LACTOFERRIN; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED F344; UP-REGULATION;

EID: 4344590829     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.029     Document Type: Article

References (49)

1. Aisen P., Listowsky I. Iron transport and storage proteins. Ann. Rev. Biochem. 49:1980;357-393
2. Masson P.L., Heremans J.F., Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130:1969;643-658
3. Lonnerdal B., Iyer S. Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr. 15:1995;93-110
4. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today. 16:1995;417-419
5. Bezault J., Bhimani R., Wiprovnick J., Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54:1994;2310-2312
6. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:1995;55-71
7. Magnuson B.A., Carr I., Bird R.P. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53:1993;4499-4504
8. Sekine K., Ushida Y., Kuhara T., ligo M., Baba-Toriyama H., Moore M.A., et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121:1997;211-216
9. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D.J., Asamoto M., et al. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88:1997;523-526
10. Ushida Y., Sekine K., Kuhara T., Takasuka N., Iigo M., Maeda M., Tsuda H. Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn. J. Cancer Res. 90:1999;262-267
11. Tanaka T., Kawabata K., Kohno H., Honjo S., Murakami M., Ota T., Tsuda H. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn. J. Cancer Res. 91:2000;25-33
12. Masuda C., Wanibuchi H., Sekine K., Yano Y., Otani S., Kishimoto S.T., Tsuda H., Fukushima S. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis. Jpn. J. Cancer Res. 91:2000;582-588
13. Fujita K., Ohnishi T., Sekine K., Iigo M., Tsuda H. Down-regulation of 2-amino-3, 8-dimethylimidazo [4, 5-f] quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Jpn. J. Cancer Res. 93:2002;616-625
14. Tsuda H., Sekine K., Fujita K., Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem. Cell Biol. 80:2002;131-136
15. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376
16. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:2001;41-49
17. Shau H., Kim A., Golub H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol. 51:1992;343-349
18. Horwits D.A., Bakke A.C., Abo W., Nishiya K. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J. Immunol. 132:1984;2370-2374
19. Vujanovic N.L. Role of TNF family ligands in antitumor activity of natural killer cells. Intern. Rev. Immunol. 20:2001;415-437
20. Smyth M.J., Hayakawa Y., Takeda K., Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer. 2:2002;850-861
21. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365
22. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308
23. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326
24. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911
25. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891
26. Kimura K., Wakatsuki T., Yamamoto M. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem. Biophys. Res. Commun. 198:1994;666-674
27. Himmler A., Maurer-Fogy I., Kronke M., Scheurich P., Pfizenmaier K., Lantz M., et al. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 9:1990;705-715
28. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178
29. Kwon J., Chung I.Y., Benveniste E.N. Cloning and sequence analysis of the rat tumor necrosis factor-encoding genes. Gene. 132:1993;227-236
30. Sato T., Irie S., Krajewski S., Reed J.C. Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein. Gene. 140:1994;291-292
31. long messenger ribonucleic acid levels. Endocrinology. 136:1995;232-241
32. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619
33. Farrow S.N., White J.H., Martinou I., Raven T., Pun K.T., Grinham C.J., et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733
34. Wang K., Yin X.M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:1996;2859-2869
35. Hsu S.Y., Kaipia A., Zhu L., Hsueh A.J. Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol. Endocrinol. 11:1997;1858-1867
36. Feng L., Sun W., Xia Y., Tang W.W., Chanmugam P., Soyoola E., et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307:1993;361-368
37. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res. 11:1983;1759-1771
38. Yoshimi N., Sato S., Makita H., Wang A., Hirose Y., Tanaka T., Mori H. Expression of cytokines, TNF-α and IL-1α, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis. 15:1994;783-785
39. Gustafson-Svard C., Hallbook O., Sjodahl R. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut. 38:1996;79-84
40. Muller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188:1998;2033-2045
41. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria to activation of cell surface death receptor. Cell. 94:1998;481-490
42. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., El-Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4:2002;842-849
43. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299
44. Shivapurkar N., belinsky S.A., Wolf D.C., Tang Z., Alabaster O. Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane. Cancer Lett. 96:1995;63-70
45. Keane M.M., Ettenberg S.A., Lowrey G.A., Russell E.K., Lipkowitz S. Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56:1996;4791-4798
46. Wang W.P., Iigo M., Sato J., Sekine K., Adachi I., Tsuda H. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 91:2000;1022-1027
47. Chulada P.C., Thompson M.B., Mahler J.F., Doyle C.M., Gaul B.W., Lee C., et al. Genetic disruption of Ptgs-1, as well as Ptsg-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 60:2000;4705-4708
48. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809
49. Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M.A., Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis. 17:1999;35-40